Literature DB >> 14532231

Amplified-fragment length polymorphism as a complement to IS6110-based restriction fragment length polymorphism analysis for molecular typing of Mycobacterium tuberculosis.

Monserrat Ruiz1, Juan Carlos Rodríguez, Francisco Rodríguez-Valera, Gloria Royo.   

Abstract

The amplified-fragment length polymorphism (AFLP) technique was applied to clusters of Mycobacterium tuberculosis clinical isolates obtained by using IS6110-based restriction fragment length polymorphism (RFLP). Ten of the RFLP clusters showed identical AFLP patterns also, but the other 13 could be resolved into subclusters by AFLP. Our results suggest that some RFLP clusters may not be due to recent transmission and that AFLP may be a useful complementary technique.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14532231      PMCID: PMC294958          DOI: 10.1128/JCM.41.10.4820-4822.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  The use of RFLP as a tool for tuberculosis control: utility or futility?

Authors:  N E Dunlap
Journal:  Int J Tuberc Lung Dis       Date:  2000-12       Impact factor: 2.373

2.  Molecular epidemiology of tuberculosis in Elche, Spain: a 7-year study.

Authors:  M Ruiz Garcia; J C Rodríguez; J F Navarro; S Samper; C Martín; G Royo
Journal:  J Med Microbiol       Date:  2002-03       Impact factor: 2.472

3.  FAFLP: last word in microbial genotyping?

Authors: 
Journal:  J Med Microbiol       Date:  2001-05       Impact factor: 2.472

4.  The molecular epidemiology of tuberculosis in Zaragoza, Spain: a retrospective epidemiological study in 1993.

Authors:  S Samper; M J Iglesias; M J Rabanaque; M A Lezcano; L A Vitoria; M C Rubio; R Gómez-Lus; L I Gómez; I Otal; C Martín
Journal:  Int J Tuberc Lung Dis       Date:  1998-04       Impact factor: 2.373

5.  Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology.

Authors:  J D van Embden; M D Cave; J T Crawford; J W Dale; K D Eisenach; B Gicquel; P Hermans; C Martin; R McAdam; T M Shinnick
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

6.  Evaluation of amplified fragment length polymorphism analysis for inter- and intraspecific differentiation of Mycobacterium bovis, M. tuberculosis, and M. ulcerans.

Authors:  G Huys; L Rigouts; K Chemlal; F Portaels; J Swings
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

7.  Genome-sequence-based fluorescent amplified-fragment length polymorphism analysis of Mycobacterium tuberculosis.

Authors:  J N Goulding; J Stanley; N Saunders; C Arnold
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

8.  Genetic diversity of Mycobacterium tuberculosis in Sicily based on spoligotyping and variable number of tandem DNA repeats and comparison with a spoligotyping database for population-based analysis.

Authors:  C Sola; S Ferdinand; C Mammina; A Nastasi; N Rastogi
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

9.  A combination of two genetic markers is sufficient for restriction fragment length polymorphism typing of Mycobacterium tuberculosis complex in areas with a high incidence of tuberculosis.

Authors:  V Rasolofo-Razanamparany; H Ramarokoto; G Aurégan; B Gicquel; S Chanteau
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

  9 in total
  2 in total

1.  An improved fluorescent amplified fragment length polymorphism method for typing Mycobacterium tuberculosis.

Authors:  Yankuba Kassama; Michael Shemko; Nandini Shetty; Zack Fang; Graham Macintire; Vanya Gant; Ali Zumla; Royston Goodacre
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

Review 2.  Molecular Strain Typing of Mycobacterium tuberculosis: a Review of Frequently Used Methods.

Authors:  Phyu Win Ei; Wah Wah Aung; Jong Seok Lee; Go Eun Choi; Chulhun L Chang
Journal:  J Korean Med Sci       Date:  2016-11       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.